Oral Leukoplakia and Erythroplakia

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2023
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Autores
SANTOS-SILVA, A. R.
ALVES, F. A.
FONSECA, F. P.
SCARINI, J. F.
INNOCENTINI, L. M. A. R.
LOPES, M. A.
Citação
Santos-Silva, A. R.; Alves, F. A.; Fonseca, F. P.; Scarini, J. F.; Innocentini, L. M. A. R.; Kowalski, L. P.; Lopes, M. A.. Oral Leukoplakia and Erythroplakia. In: . Clinical Decision-Making in Oral Medicine: A Concise Guide to Diagnosis and Treatment: SPRINGER INTERNATIONAL PUBLISHING, 2023. p.141-146.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Leukoplakia and erythroplakia are the two most common potentially malignant disorders of the oral cavity. Both lesions in a small and significant proportion of cases, respectively, turn into cancer. Most lesions are asymptomatic, and the main objective of treatment is to prevent their malignant transformation. The role of the dentist in the diagnosis and management cannot be underestimated, and this chapter provides an overview of the current concepts and practical diagnosis and treatment guidelines based on our clinical experience. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.
Palavras-chave
Alcohol, Erythroleukoplakia, Erythroplakia, Oral cancerOral leukoplakia, Oral potentially malignant disorders, Proliferative verrucous leukoplakia, Tobacco
URI
https://observatorio.fm.usp.br/handle/OPI/57171
Referências
  1. Amagasa T., Yamashiro M., Uzawa N., Oral premalignant lesions: From a clinical perspective, Int J Clin Oncol, 16, pp. 5-14, (2011)
  2. A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia, Front Oral Health, (2023)
  3. Awadallah M., Idle M., Patel K., Kademani D., Management update of potentially premalignant oral epithelial lesions, Oral Surg Oral Med Oral Pathol Oral Radiol, 125, 6, pp. 628-636, (2018)
  4. Brennan M., Migliorati C.A., Lockhart P.B., Wray D., Al-Hashimi I., Axell T., Bruce A.J., Carpenter W., Eisenberg E., Epstein J.B., Holmstrup P., Jontell M., Nair R., Sasser H., Schifter M., Silverman B., Thongprasom K., Thornhill M., Warnakulasuriya S., van der Waal I., Management of oral epithelial dysplasia: A review, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, pp. e1-12, (2007)
  5. Brennan M., Migliorati C.A., Lockhart P.B., Wray D., Al-Hashimi I., Axell T., Bruce A.J., Carpenter W., Eisenberg E., Epstein J.B., Holmstrup P., Jontell M., Nair R., Sasser H., Schifter M., Silverman B., Thongprasom K., Thornhill M., Warnakulasuriya S., van der Waal I., Management of oral epithelial dysplasia: A review, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, pp. e1-12, (2007)
  6. Celentano A., Glurich I., Borgnakke W.S., Farah C.S., World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies, Oral Dis, 27, 4, pp. 848-880, (2021)
  7. Cerqueira J.M., Pontes F.S., Santos-Silva A.R., Almeida O.P., Costa R.F., Fonseca F.P., Gomez R.S., Neto N.C., Miyahara L.A., Rodrigues-Fernandes C.I., Neto E.D., Araujo A.L., Malignant transformation of oral leukoplakia: A multicentric retrospective study in Brazilian population, Med Oral Patol Oral Cir Bucal, 26, 3, pp. e292-e298, (2021)
  8. Chuang S.L., Wang C.P., Chen M.K., Su W.W., Su C.W., Chen S.L., Chiu S.Y., Fann J.C., Yen A.M., Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program, Oral Oncol, 87, pp. 58-63, (2018)
  9. de Pauli P.M., Migliorati C.A., Schausltz Pereira Faustino I., Linhares Almeida Mariz B.A., Oliveira Correa Roza A.L., Agustin Vargas P., Franco Paes Leme A., Bianca Brandao T., Prado Ribeiro A.C., Ajudarte Lopes M., Santos-Silva A.R., Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis, Oral Oncol, 109, (2020)
  10. Goodson M.L., Sloan P., Robinson C.M., Cocks K., Thomson P.J., Oral precursor lesions and malignant transformation–who, where what, and when?, Br J Oral Maxillofac Surg, 53, 9, pp. 831-835, (2015)
  11. Gouvea A.F., Moreira A.E., Reis R.R., de Almeida O.P., Lopes M.A., Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis, Med Oral Patol Oral Cir Bucal, 15, 5, pp. e704-e708, (2010)
  12. Holmstrup P., Oral erythroplakia-what is it?, Oral Dis, 24, 1-2, pp. 138-143, (2018)
  13. IARC Perspective on Oral Cancer Prevention, N Engl J Med, 387, 21, pp. 1999-2005, (2022)
  14. Jeong W.J., Paik J.H., Cho S.W., Sung M.W., Kim K.H., Ahn S.H., Excisional biopsy for management of lateral tongue leukoplakia, J Oral Pathol Med, 41, 5, pp. 384-388, (2012)
  15. Lingen M.W., Abt E., Agrawal N., Chaturvedi A.K., Cohen E., D'souza G., Gurenlian J., Kalmar J.R., Kerr A.R., Lambert P.M., Patton L.L., Sollecito T.P., Truelove E., Tampi M.P., Urquhart O., Banfield L., Carrasco-Labra A., Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American dental association, J am Dent Assoc, 148, 10, pp. 712-727, (2017)
  16. Lodi G., Sardella A., Bez C., Demarosi F., Carrassi A., Interventions for treating oral leukoplakia, Cochrane Database Syst Rev, 4, (2008)
  17. Lopes M.A., Proliferative verrucous leukoplakia may initially mimic lichenoid reactions, World J Clin Cases, 3, 10, pp. 861-865, (2015)
  18. Malignant transformation of oral leukoplakia: A multicentric retrospective study in Brazilian population, Med Oral Patol Oral Y Cir Bucal, pp. e292-e298, (2021)
  19. Muller S., Tilakaratne W.M., Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue, Head Neck Pathol, 16, 1, pp. 54-62, (2022)
  20. Oral leukoplakia in adolescents: Report of a rare case and review of the literature, Oral Oncol, 122, (2021)
  21. Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia, Oral Oncol, 116, (2021)
  22. Paglioni M.P., Khurram S.A., Ruiz B.I.I., Lauby-Secretan B., Normando A.G., Ribeiro A.C.P., Brandao T.B., Palmier N.R., Lopes M.A., da Silva Guerra E.N., Meleti M., Migliorati C.A., Carvalho A.L., de Matos L.L., Kowalski L.P., Santos-Silva A.R., Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis, Oral Surg Oral Med Oral Pathol Oral Radiol, 4403, 22, pp. 01054-01059, (2022)
  23. Pindborg J.J., Reichart P.A., Smith C.J., World Health Organization: Histological Typing of Cancer and Precancer of the Oral Mucosa, (1997)
  24. Robledo-Sierra J., Ben-Amy D.P., Varoni E., Bavarian R., Simonsen J.L., Paster B.J., Wade W.G., Kerr R., Peterson D.E., Frandsen L.E., World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders, Oral Dis, 25, pp. 28-48, (2019)
  25. Rodrigues-Fernandes C.I., Arboleda L.P.A., Vargas P.A., Lopes M.A., Santos-Silva A.R., Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia, Oral Oncol, 116, (2021)
  26. Speight P.M., An overview of the classification and predictive value of oral epithelial dysplasia, IAOP, (2010)
  27. Sperandio M., Warnakulasuriya S., Soares A.B., Passador-Santos F., Mariano F.V., Lima C.S.P., Scarini J.F., Dominguete M.H.L., de Camargo M.P., Montalli V.A.M., Hellmeister L., de Araujo V.C., Oral epithelial dysplasia grading: Comparing the binary system to the traditional 3-tier system, an actuarial study with malignant transformation as outcome, J Oral Pathol Med, (2022)
  28. Stojanov I.J., Woo S.B., AAOM clinical practice statement subject: Leukoplakia, Oral Surg Oral Med Oral Pathol Oral Radiol, 126, 4, pp. 331-334, (2018)
  29. van der Waal I., Potentially malignant disorders of the oral and oropharyngeal mucosa
  30. terminology, classification and present concepts of management, Oral Oncol, 45, 4-5, pp. 317-323, (2009)
  31. Villa A., Celentano A., Glurich I., Borgnakke W.S., Jensen S.B., Peterson D.E., Delli K., Ojeda D., Vissink A., Farah C.S., World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies, Oral Dis, 25, pp. 64-78, (2019)
  32. Villa A., Menon R.S., Kerr A.R., de Abreu A.F., Guollo A., Ojeda D., Woo S.B., Proliferative leukoplakia: Proposed new clinical diagnostic criteria, Oral Dis, 24, 5, pp. 749-760, (2018)
  33. Warnakulasuriya S., Clinical features and presentation of oral potentially malignant disorders, Oral Surg Oral Med Oral Pathol Oral Radiol, 125, 6, pp. 582-590, (2018)
  34. Wei L., Wang Y.-F., Zhou H.-W., Shi P., Zhou Z.-T., Tan G.-Y., Malignant transformation of oral leukoplakia: A retrospective cohort study of 218 Chinese patients, BMC Cancer, 10, (2010)
  35. Pathology and Genetics of Head and Neck Tumors: Classification of Tumors, pp. 283-327, (2005)

Coleções
Livros e Capítulos de Livros - FM/MCG
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - LIM/28
Livros e Capítulos de Livros - ODS/03